{
    "root": "30535278-6d30-76bd-e063-6294a90a7534",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Pregabalin",
    "value": "20250314",
    "ingredients": [
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "SHELLAC",
            "code": "MB5IUD6JUA"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "PREGABALIN",
            "code": "55JG375S6M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64356"
        }
    ],
    "indications": {
        "text": "pregabalin capsule indicated : management neuropathic pain associated diabetic peripheral neuropathy management postherpetic neuralgia adjunctive therapy treatment partial onset seizures patients 17 years age older management fibromyalgia management neuropathic pain associated spinal cord injury pediatric information approved pfizer 's lyrica ( pregabalin ) capsules oral solution products . however , due pfizer 's marketing exclusivity rights , product labeled pediatric information .",
        "doid_entities": [
            {
                "text": "peripheral neuropathy (DOID:574)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_574"
            },
            {
                "text": "neuropathy (DOID:870)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_870"
            },
            {
                "text": "fibromyalgia (DOID:631)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_631"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adult , begin dosing 150 mg/day . ( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) dosing recommendations : indication dosing regimen maximum dose dpn pain ( 2.2 ) 3 divided doses per day 300 mg/day within 1 week phn ( 2.3 ) 2 3 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day adjunctive therapy partial-onset seizures adult patients 17 years age older ( 2.4 ) 2 3 divided doses per day maximum dose 600 mg/day fibromyalgia ( 2.5 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 450 mg/day neuropathic pain associated spinal cord injury ( 2.6 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day \u2022 dose adjusted adult patients reduced renal function . ( 2.7 )",
        "doid_entities": [
            {
                "text": "fibromyalgia (DOID:631)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_631"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "75 mg capsules white white color granular powder filled size `` 4 `` hard gelatin capsules white opaque body imprinted `` pgbn `` light blue opaque cap imprinted `` 75 `` black ink available : ndc : 70518-2525-00 ndc : 70518-2525-01 ndc : 70518-2525-02 packaging : 90 1 bottle plastic packaging : 60 1 bottle plastic packaging : 30 1 blister pack storage handling store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) ( usp controlled room temperature ) . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "pregabalin contraindicated patients known hypersensitivity pregabalin components . angioedema hypersensitivity occurred patients receiving pregabalin therapy [ ( 5.2 ) ] .",
    "indications_original": "Pregabalin capsule is indicated for:\n                  \n                  \n                     \n                        Management of neuropathic pain associated with diabetic peripheral neuropathy\n                     \n                     \n                        Management of postherpetic neuralgia\n                     \n                     \n                        Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older\n                     \n                     \n                        \u00a0Management of fibromyalgia\n                     \n                     \n                        Management of neuropathic pain associated with spinal cord injury\n                     \n                  \n                  \n                     Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral\u00a0 Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product\u00a0 is not labeled with that pediatric information.",
    "contraindications_original": "For adult indications, begin dosing at 150 mg/day. (2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN Pain (2.2) 3 divided doses per day 300 mg/day within 1 week PHN (2.3) 2 or 3 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day Adjunctive Therapy for Partial-Onset Seizures in Adult Patients 17 Years of Age and Older (2.4) 2 or 3 divided doses per day Maximum dose of 600 mg/day Fibromyalgia (2.5) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 450 mg/day Neuropathic Pain Associated with Spinal Cord Injury (2.6) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day \u2022\u00a0Dose should be adjusted in adult\u00a0patients with reduced renal function. (2.7)",
    "warningsAndPrecautions_original": "75 mg capsules\n                  White to off White color granular powder filled in Size \"4\" hard gelatin capsules with White Opaque body imprinted \"PGBN\" and light blue Opaque cap imprinted \"75\" with black ink available in:\n                  NDC: 70518-2525-00\n                  NDC: 70518-2525-01\n                  NDC: 70518-2525-02\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Storage and Handling\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) (see USP Controlled Room Temperature).\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. Angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy \n       \n \n  \n                        [see Warnings and Precautions (5.2)].",
    "drug": [
        {
            "name": "Pregabalin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64356"
        }
    ]
}